课题: 1. 2009年获上海市科委课题(自然科学基金):骨髓衍生干细胞在炎症相关性大肠癌发生过程中的作用机制探讨。 2. 爱必妥联合FOLFOX4方案一线治疗mCRC(TAILOR)的随机多中心研究(申办方:默克;III期) 3. Regorafenib3线治疗转移性结直肠癌Ⅲ期研究:亚太随机多中心研究(CONCUR)(申办方:拜耳;III期) 4. 阿柏西普联合FOLFIRI2线治疗MCRC(Aflame):亚太随机多中心研究(申办方:赛诺菲;III期) 5. 百杰依治疗血小板减少IV期观察性研究(申办方:贵州益佰;IV期) 6. 赫赛汀高剂量及低剂量比较治疗晚期胃癌(HELOISE)的全球随机多中心研究(申办方:罗氏;IIIb期) 发表论文: 1. Le-Chi Ye, Tian-Shu Liu (共同第一作者), Li Ren, Ye Wei, De-Xiang Zhu, Sheng-Yong Zai, Qing-Hai Ye, Yiyi Yu, Bo Xu,Xin-Yu Qin, and Jianmin Xu Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases Journal of Clinical Oncology 2013 April ,DOI 10.1200/JCO.2012.44.8308 2. Jianlan Cui, Xueya Cai , Min Zhu, Tianshu Liu4(共同通讯)*, Naiqing Zhao1,5*.The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials PlOS ONE 2013;8(4) e62038 3. Yuehong Cui,Qian Li,Yiyi Yu,Yong Chen,Yi Feng,Yan Wang,Tianshu Liu*. Combination of low-dose docetaxel and standard dose of S-1 for the treatment of advanced gastric cancer: efficacy, toxicity and potential predictive factor. Cancer Chemotherapy and pharmacology 2012 DOI 10.1007/s00280-012 4. Cui YH, Liu TS, Zhou YH, et al. Five cases report of solid tumor synchronously with hematologic malignancy. Cancer Research and Treatment,2012 5. Zhiming Wang*,Yuehong Cui*,Wei Li, Shiyao Chen,Tianshu Liu. Lentiviral-mediated siRNA targeted against osteopontinsuppresses the growth and metastasis of gastric cancer cells Oncology reports 2011, DOI: 10.3892/or.2011.1168 6. Wei Li, Jing Qin, Yi-Hong Sun, Tian-Shu Liu. Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis World J Gastroenterol 2010 November 21; 16(43): -0000 7. Yuehong CUI, Tianshu LIU (corresponding author), Rongyuan ZHUANG, et al. Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer [J]. Journal of Digestive Disease 2009; 10: 118-123. 8. TS Liu, Y Wang, SY Chen, YH Sun.. An updated meta-analysis of adjuvant chemotherapy after curative resection of gas tric cancer [J]. Eur J Sur Oncol 2008; 34:1208-1216. 9. 余一祎,刘天舒*,王志明,李伟.AJCC新分期(2010年版)对胃癌根治术后辅助化疗选择的影响 .中华胃肠外科杂志,2012,15(06):599-602. 10. 李倩,刘天舒*,崔越宏等,小剂量多西他赛联合替吉奥一线治疗晚期胃癌的单中心临床研究,中国癌症杂志,2012(22):602-607 11. 李伟,刘天舒*,孙益红,沈坤堂,沈振斌,王志明,崔越宏,余一祎。胃癌术后辅助化疗两药和三药方案的选择[J] 中华胃肠外科杂志 2011;14(6):432-435 12. 刘天舒,余一祎,陈英耀.转移性结直肠癌不同化疗方案的成本效果分析[J].中华胃肠外科杂志, 2008;11(2):120-123 13. 崔越宏,刘天舒*,陈世耀等.骨桥蛋白反义寡核苷酸抑制胃癌细胞MKN28粘附侵袭的实验研究[J].临床肿瘤学杂志,2008;13(7):585-589 14. 崔越宏,刘天舒*,周宇红等.骨桥蛋白反义寡核苷酸抑制卵巢癌细胞SKOV3粘附侵袭的实验研究[J].实用肿瘤杂志,2008;38(5):415-420 15. 庄荣源, 刘天舒*,金文等. 西妥昔单抗联合化疗治疗晚期恶性肿瘤的临床分析[J]. 中国临床医学杂志,2008,15(增刊):122-124 |